George Kunos

USPTO Granted Patents = 12 (Patent Applications = 6)

CIPO Patents = 2

EPO Patents = 4 (Patent Applications = 8)

Average Co-Inventor Count = 3.5

ph-index = 4

Forward Citations = 60(Granted Patents)

Company Filing History:

10 out of 3,435

National Institutes of Health, a Component of the US Dept. of Health & Human Services

patents

2 out of 402

Virginia Commonwealth University

University of Massachusetts

patents

where one patent can have more than one assignee

Years Active: 1999-2024

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11939297 - Cannabinoid receptor mediating compounds (2024-03-26),

2. 11485709 - Cannabinoid receptor mediating compounds (2022-11-01),

3. 11155521 - Cannabinoid receptor mediating compounds (2021-10-26),

4. 10787419 - Cannabinoid receptor mediating iminopyrazole compounds (2020-09-29),

5. 10683270 - Cannabinoid receptor mediating compounds (2020-06-16),

6. 10329259 - Pyrazole derivatives and their use as cannabinoid receptor mediators (2019-06-25),

7. 10077446 - Glucan-encapsulated siRNA for treating type 2 diabetes mellitus (2018-09-18),

8. 9765031 - Cannabinoid receptor mediating compounds (2017-09-19),

9. 8293724 - Therapeutic applications of fatty acid amide hydrolase inhibitors (2012-10-23),

10. 7109245 - Vasoconstrictor cannabinoid analogs (2006-09-19),

11. 6563009 - Vasodilator cannabinoid analogs (2003-05-13),

12. 5939429 - Cardiovascular uses of cannabinoid compounds (1999-08-17),

Title: The Innovative Contributions of George Kunos

Introduction

George Kunos is a prominent inventor based in Bethesda, MD (US), known for his significant contributions to the field of cannabinoid research. With a total of 12 patents to his name, Kunos has made remarkable strides in developing therapeutic compounds that target cannabinoid receptors.

Latest Patents

Among his latest patents, Kunos has developed cannabinoid receptor mediating compounds. These compounds consist of a CB receptor mediating scaffold conjugated to a second therapeutic scaffold, which may include pharmaceutically acceptable salts or esters. This innovative approach aims to enhance the efficacy of cannabinoid-based therapies.

Career Highlights

Kunos has had a distinguished career, working with esteemed institutions such as the National Institutes of Health, a component of the US Department of Health & Human Services, and Virginia Commonwealth University. His work has significantly advanced the understanding of cannabinoid receptors and their potential therapeutic applications.

Collaborations

Throughout his career, Kunos has collaborated with notable colleagues, including Malliga R. Iyer and Resat Cinar. These collaborations have fostered a rich environment for innovation and research in cannabinoid science.

Conclusion

George Kunos's contributions to cannabinoid research and his impressive portfolio of patents underscore his role as a leading inventor in the field. His work continues to pave the way for new therapeutic options and advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.